This inventor holds 1 USPTO granted patent. Top assignee: University of Virginia Patent Foundation. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Kirsten Greene: Innovator in Autoimmune Disease Treatment
Introduction
Kirsten Greene is a notable inventor based in Baltimore, MD (US). She has made significant contributions to the field of autoimmune disease treatment through her innovative research and patent.
Latest Patents
Kirsten Greene holds a patent for "Antigen-based heteropolymers and method for treating autoimmune diseases." This patent involves constructs consisting of antigen-based heteropolymers (AHP's) that include at least one monoclonal antibody specific for binding to the complement receptor (CR1) site on human or non-human primate erythrocytes. The anti-CR1 monoclonal antibody is crosslinked to an antigen specific for a target pathogenic autoantibody. The method provided in the patent aims to treat autoimmune diseases in both human and non-human primates using the AHP.
Career Highlights
Kirsten Greene is affiliated with the University of Virginia, where she continues her research and development in the field of immunology. Her work has garnered attention for its potential impact on treating autoimmune conditions.
Collaborations
Kirsten has collaborated with esteemed colleagues, including Ronald P. Taylor and Polly J. Ferguson, who have contributed to her research endeavors.
Conclusion
Kirsten Greene's innovative work in developing antigen-based heteropolymers represents a significant advancement in the treatment of autoimmune diseases. Her contributions to science and medicine continue to inspire future research in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile